Noncoding RNAs in Pediatric Solid Tumors: Advances in Understanding and Critical Knowledge Gaps

Area of Science:

• Pediatric Oncology
• Molecular Biology
• Epigenetics

Background:

• Pediatric cancers stem from developmental dysregulation, differing from adult cancers.
• While survival rates have improved for some pediatric cancers, many require novel therapeutic strategies.
• Understanding the unique genetic and epigenetic landscape of pediatric tumors is crucial.

Purpose of the Study:

• To review the role of non-coding RNAs (ncRNAs) in pediatric solid tumors.
• To explore the potential of ncRNAs as biomarkers and therapeutics.
• To identify knowledge gaps in ncRNA research for improving pediatric cancer outcomes.

Main Methods:

• Literature review of current knowledge on ncRNAs in pediatric solid tumors.
• Examination of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs).
• Discussion of potential clinical applications and future research directions.

Main Results:

• ncRNAs play significant roles in the epigenetic regulation of pediatric cancers.
• Specific ncRNAs are implicated in tumor onset, progression, and response to therapy.
• ncRNAs show promise as diagnostic biomarkers and therapeutic targets.

Conclusions:

• ncRNAs represent a critical area for future research in pediatric oncology.
• Targeting ncRNAs may offer novel therapeutic avenues for improving patient outcomes.
• Further investigation into ncRNA mechanisms and clinical utility is warranted.